Frequency and parameters of linkage disequilibrium of the two-locus <i>HLA-B~MICA</i> haplotypes in russians from chelyabinsk region
-
Published:2022-09-01
Issue:2
Volume:25
Page:139-146
-
ISSN:1028-7221
-
Container-title:Russian Journal of Immunology
-
language:
-
Short-container-title:Russian Journal of Immunology
Author:
Vavilov Mikhail N.,Suslova Tatiana A.,Burmistrova Aleksandra L.
Abstract
MICA gene is located in the MHC region on chromosome 6p21.33, mapped ca. 46.4 kb centromeric to the HLA-B gene, being in strict linkage disequilibrium with MHC class I region. The sufficient polymorphism of human MICA gene and its location at the HLA region makes it a likely candidate locus for additional histocompatibility testing. The data on distribution of two-locus HLA-B~MICA haplotypes enable us to obtain information about the level of mismatches in the MICA locus when selecting suitable donor-recipient pair by convential HLA loci for unrelated hematopoietic stem cell transplantation. We have performed immunogenetic typing of 100 donors of Russian Nationality from the Register of Stem Cell Donors at Chelyabinsk Regional Blood Bank. MICA genotyping was carried out by PCR tests with sequence-specific primers at basic resolution. Typing of the classical HLA-B locus was carried out by the NGS method using MiSeq instrument using a MiSeq v2 reagent kit (Illumina). Linkage disequilibrium indices D, D`, p, and the frequency of two-locus HLA-B~MICA haplotypes were calculated using Arlequin 3.5 software. As a result of this study, the main parameters of linkage disequilibrium and the frequency of two-locus HLA-B~MICA haplotypes were established for Russians from the Chelyabinsk region. HLA-B allelic groups have been identified that form stable pairs with specific MICA allelic variants (HLA-B*B*07, B*08, B*13, B*14, B* 27, B*37, B*38, B*47, B *48, B*49, B*50, B*52, B*55, B*56, B*57). Moreover, we have revealed HLA-B allelic groups forming highly variable HLA-B~MICA haplotypes (HLA-B*15, B*18, B*35, B*39, B*40, B*41, B*44 and B*51) with increased risk of mismatch for MICA genes. These results could be used in clinical practice in order to assess probability of the donor/recipient mismatch for non-classic MICA locus when selecting potential stem cell donors for hematological patients by HLA testing of classical loci. Moreover, these data could be demanded in population genetics.
Publisher
Russian Society of Immunology
Subject
Immunology,General Medicine
Reference13 articles.
1. Anderson E., Grzywacz B., Wang H., Wang T., Haagenson M., Spellman S., Blazar B.R., Miller J.S., Verneris M.R. Limited role of MHC class I chain-related gene a (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation. Blood, 2009, Vol. 114, no. 21, pp. 4753-4754. 2. Arlequin: An Integrated Software for Population Genetics Data Analysis [cmpg.unibe.ch]. Arlequin ver 3.5.2.2 [released on 02.08.2015; date of access May 2022]. Available at: http://cmpg.unibe.ch/software/arlequin35/. 3. Carapito R., Jung N., Kwemou M., Untrau M., Michel S., Pichot A., Giacometti G., Macquin C., Ilias W., Morlon A., Kotova I., Apostolova P., Schmitt-Graeff A., Cesbron A., Gagne K., Oudshoorn M., Holt B., Labalette M., Spierings E., Picard C., Loiseau P., Tamouza R., Toubert A., Parissiadis A., Dubois V., Lafarge X., Maumy-Bertrand M., Bertrand F., Vago L., Ciceri F., Paillard C., Querol S., Sierra J., Fleischhauer K., Nagler A., Labopin M., Inoko H., Borne P., Kuball J., Ota M., Katsuyama Y., Michallet M., Lioure B., Latour R.P., Blaise D., Cornelissen J.J., Yakoub-Agha I., Claas F., Moreau P., Milpied N., Charron D., Mohty M., Zeiser R., Socié G., Bahram S. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD. Blood, 2016, Vol. 128, no. 15, pp. 1979-1986. 4. Chen D., Gyllensten U. MICA polymorphism: biology and importance in cancer. Carcinogenesis, 2014, Vol. 35, no. 12, pp. 2633-2642. 5. Collins R.W.M. Human MHC class I chain related (MIC) genes: Their biological function and relevance to disease and transplantation. Eur. J. Immunogenet., 2004, Vol. 31, no. 3, pp. 105-114.
|
|